Directors

Blueprint Medicines Appoints John Tsai, MD to its Board of Directors |  citybiz

Blueprint Medicines Appoints John Tsai, MD to its Board of Directors | citybiz

John Tsai, MD, Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of John Tsaidoctor, to its board of directors. Dr. Tsai, who served as President of Global Drug Development and Chief Medical Officer at Novartis AG from 2018 to 2022, brings to Blueprint Medicines more than 20 years of experience in drug development and …

Blueprint Medicines Appoints John Tsai, MD to its Board of Directors | citybiz Read More »

Blueprint Medicines Appoints John Tsai, MD to its Board of Directors

Blueprint Medicines Appoints John Tsai, MD to its Board of Directors

CAMBRIDGE, Mass., January 6, 2023 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of John Tsai, MD, to its Board of Directors. Dr. Tsai, who served as President of Global Drug Development and Chief Medical Officer at Novartis AG from 2018 to 2022, brings to Blueprint Medicines more than 20 years of …

Blueprint Medicines Appoints John Tsai, MD to its Board of Directors Read More »

Alex Azar Joins AbsoluteCare Board of Directors

Alex Azar Joins AbsoluteCare Board of Directors

Former U.S. Secretary of Health and Human Services lends expertise COLUMBIA, MD., January 6, 2023 /PRNewswire/ — AbsoluteCare, a PCP-focused concierge model of care serving the most medically complex and compromised members, is pleased to welcome the 24e United States Secretary of Health and Human Services (HHS), Alex Azarto our board of directors. As Secretary …

Alex Azar Joins AbsoluteCare Board of Directors Read More »

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces Progress of Phase 1b SER-155 Study

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces Progress of Phase 1b SER-155 Study

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the appointment of Claire M. Fraser, Ph.D., to its Board of Directors. Dr. Fraser will begin serving on the Seres Board of Directors, effective immediately. “It is an incredibly exciting time to join Seres’ Board of Directors as the company prepares for its first potential product …

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces Progress of Phase 1b SER-155 Study Read More »

Brightside Health Welcomes Jeff Margolis and David Shulkin to Board of Directors and Advisors

Brightside Health Welcomes Jeff Margolis and David Shulkin to Board of Directors and Advisors

Health industry experts to provide advice as the company rapidly grows and adopts telemental health more widely SAN FRANCISCO, December 06, 2022–(BUSINESS WIRE)–Brightside Health, a telehealth platform that provides life-changing mental health care for people with mild to severe clinical depression, anxiety and other mood disorders, has today announced the appointment of health industry experts …

Brightside Health Welcomes Jeff Margolis and David Shulkin to Board of Directors and Advisors Read More »

Mitigating Burnout for Internal Medicine Program Directors

Mitigating Burnout for Internal Medicine Program Directors

Institutions offering internal medicine residency programs have the opportunity to reduce the barriers faced by directors of these programs to help mitigate burnout. An internal medicine residency program director must ensure that interns and medical residents acquire the knowledge, skills, and attitudes necessary to practice their chosen specialty independently and competently. What else do residency …

Mitigating Burnout for Internal Medicine Program Directors Read More »